Pfizer's robust R&D pipeline is expected to drive future growth and offset patent expirations. Read why I maintain my buy ...

Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve Worland, Ph.D. as Chief ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

The best way to beat persistent inflation is to invest in businesses unaffected by rising prices, like these four high-yield ...

Pfizer (PFE) is a pharmaceutical and biotechnology company valued at $145 billion by market capitalization. While the company ...

A Fond du Lac woman is suing Pfizer and others over a brain tumor, arguing it’s associated with Depo-Provera, a form of birth ...

Large American pharmaceutical companies are showing a distinct trend never seen before: they are increasingly looking for ...

Medicare changes will cut $1 billion from 2025 revenue, with Pfizer now responsible for 20% of catastrophic drug costs. Read ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.

Pfizer is doubling down on its fight against cancer with a 60-second ad set to air during the first quarter of the game.

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...